PodParley PodParley
PodParley
Stage IV Pancreatic Islet Cell Tumors: Sunitinib Doubles Progression-Free Survival in Phase III Study episode artwork

EPISODE · Jul 16, 2026 · 4 MIN

Stage IV Pancreatic Islet Cell Tumors: Sunitinib Doubles Progression-Free Survival in Phase III Study

from Oncology Times - OncTimes Talk

Eric Raymond of Beaujon University Hospital in France discusses his study reported at the ESMO World Congress on Gastrointestinal Cancer

Episode metadata supplied by the publisher feed · Published Jul 16, 2026

Embed this episode

NOW PLAYING

Stage IV Pancreatic Islet Cell Tumors: Sunitinib Doubles Progression-Free Survival in Phase III Study

0:00 4:37

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Oncology Times - OncTimes Talk?

This episode is 4 minutes long.

When was this Oncology Times - OncTimes Talk episode published?

This episode was published on July 16, 2026.

Can I download this Oncology Times - OncTimes Talk episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!